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ABSTRACT
AEBP2 is a zinc finger protein that has been
shown to interact with the mammalian Polycomb
Repression Complex 2 (PRC2). In the current
study, we characterized this unknown protein and
tested its potential targeting roles for the PRC2.
AEBP2 is an evolutionarily well-conserved gene
that is found in the animals ranging from flying
insects to mammals. The transcription of mamma-
lian AEBP2 is driven by two alternative promoters
and produces at least two isoforms of the protein.
These isoforms show developmental stage-specific
expression patterns: the adult-specific larger form
(51 kDa) and the embryo-specific smaller form (32
kDa). The AEBP2 protein binds to a DNA-binding
motif with an unusual bipartite structure, CTT(N)
15-23cagGCC with lower-case being less critical.
A large fraction of AEBP2’s target loci also map clo-
sely to the known target loci of the PRC2. In fact,
many of these loci are co-occupied by the two pro-
teins, AEBP2 and SUZ12. This suggests that AEBP2
is most likely a targeting protein for the mammalian
PRC2 complex.
INTRODUCTION
AEBP2 is a Gli-type zinc finger protein, which was orig-
inally identified due to its in vitro binding capability to the
promoter region of adipose P2 (aP2) gene encoding a fatty
acid-binding protein (1). This initial study revealed that
this protein contains three zinc finger units and a novel
basic domain, and also that this protein may function as a
repressor based on co-transfection reporter assays. Soon
afterwards, the homologous protein, called JING
(meaning ‘still’), was also isolated from Drosophila (2).
According to the results from several studies, JING is
involved in border cell migration (2) and development of
the central nervous system (3). Genetic studies further
suggested that jing may interact with the fly Polycomb
Group (PcG) protein complexes (4,5). The potential role
of AEBP2 as a component of the PcG complexes has been
further strengthened by another series of studies using the
mammalian cell line system (6). Human AEBP2 has been
co-purified with the mammalian PcG Repression Complex
2 (PRC2), and the subsequent study revealed that the
AEBP2 protein can interact with the three core compo-
nents of PRC2, including EED, SUZ12 and RbAp48, and
that the interaction of AEBP2 with these proteins
enhances the catalytic activity of the histone methylation
activity of the PRC2 complex (7).
Although the core proteins for PRC2 have been identi-
fied, the mechanism by which PRC2 is targeted to numer-
ous genomic loci is currently unknown (8). This lack of
knowledge is mainly due to the facts that the identified
core proteins do not have DNA-binding capability, and
that DNA-binding proteins have never been consistently
co-purified with the PRC2 (9–12). In Drosophila, however,
another Gli-type zinc finger gene, called pho
(Pleiohomeotic), has been shown to be a targeting protein
for its PcG complexes (13). Recent studies further con-
firmed the presence of two Pho-containing complexes,
INO80 and PhoRC, and PhoRC is now regarded as a
new member of PcG complexes based on its repression
role through another PcG protein, SFMBT [Sex comb
on middle leg-related gene with four mbt domains; (14)].
Along with the other data from several studies, this evi-
dence has long suggested that YY1 (Yin Yang 1), the
mammalian homologue of pho, might be a targeting pro-
tein for the mammalian PRC2. Nevertheless, this possibil-
ity has never been formally demonstrated so far. In that
regard, it is intriguing to point out that AEBP2 has both
DNA-binding capability and PcG connection. Thus, it has
been hypothesized that AEBP2 might be a targeting pro-
tein for the mammalian PRC2. However, very little is
known about the general aspects of AEBP2, in particular
its DNA-binding motif and downstream genes.
As part of the effort of characterizing this largely
unknown gene and to test the above possibility, we have
conducted a series of comparative genomics and DNA-
binding motif studies in the current study. According to
the results derived from this study, AEBP2 is an evolutio-
narily well-conserved protein that is found in all the ani-
mals ranging from flying insects to placental mammals.
The exon structure of mouse Aebp2 indicates the presence
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of alternative splicing involving both 50- and 30-end exons,
and subsequently two major forms of AEBP2 with differ-
ent protein sizes, 52 and 31 kDa. A series of ChIP cloning
experiments using anti-AEBP2 and -SUZ12 antibodies
also identified many in vivo target loci that are bound
by these two proteins. Subsequent gel shift assays
using the sequences obtained from these target loci
revealed one potential DNA-binding motif for AEBP2,
CTT(N)15-23cagGCC. Also, individual ChIP experiments
further demonstrated that a subset of these identified loci
are indeed occupied by both the AEBP2 and SUZ12 pro-
teins. These results are consistent with the initial predic-
tion that AEBP2 may be a targeting protein for the
mammalian PRC2 complex.
MATERIALS AND METHODS
Global protein sequence alignment
AEBP2- and JING-related sequences were collected from
NCBI, UniProt, EMBL and UCSC. ClustalW was used to
create protein alignments, and the final outcome was pro-
duced and edited using CLC free workbench version 4.0.3
(CLC bio A/S, Denmark). The protein alignment was set
using the following parameters: gap opening penalty=10,
gap extension penalty=0.1.
AEBP2 isoform confirmation through RT–PCR and
western blot
Total RNAs were isolated from several tissues of a
3-month-old male mouse using the Trizol RNA isolation
kit (Invitrogen). These RNAs were reverse-transcribed
using the RT-PCR kit (Invitrogen SuperScript system,
Invitrogen). For the 50-side splicing, the following primer
sets were used: mAebp2-a1, 50-CGGCCAGCGCTACAC
CCCAAGAACT-30; mAebp2-a2, 50-GGGGAGCCGCT
GAGCCGCATGGACT-30; and mAebp2-b, 50-GAAGC
ATGCCTGGCACTGGTC-30. For the 30-splicing, we
used the following primer sets: mAb7-F, 50-GATACTG
CCTTGCTGTTGGACC-30; mAbU2-R, 50-TCCATGCC
ATGTGGACTGCAG-30, and mAbU3-R, 50-CTCCACT
TCCACCTACAAGGA-30. The PCR with the mAb-a1
and mAb-b primer set were performed at an annealing
temperature of 61C for 35 cycles. The remaining primer
sets were amplified at an annealing temperature of 60C
for 30 cycles. For the detection of the AEBP protein, we
prepared crude tissue extracts from the brain and testis of
1-month-old mouse, and also a 14-day-old embryo using
the T-PER Tissue Protein Extraction Reagent kit (Cat.
78510, Thermo Scientific). Each extract (10 mg) was sepa-
rated on 10% SDS–PAGE, transferred on to a PVDF
membrane (Hybond-P, Amersham), and incubated with
the anti-AEBP2 polyclonal antibody (Cat. 11232-2-AP,
Proteintech Group).
AEBP2 GST fusion protein production
Three different GST fusion proteins were produced
through cloning different part of the mouse AEBP2 pro-
tein (GenBank accession no. NM_178803). To construct
these fusion constructs, we have amplified the coding
region of AEBP2 using the following primer set: Acidic-
mAb-F (50-ATGGCCGCCGCGCTCGCCGACATG-30)
as a forward primer and mAebp2-b (50-ATTGCAAATG
TCGTTCACTGTTTGCT-30) as a reverse primer for the
fusion construct I, mAebp2-a (50-ATGGACATAGACAG
CACAATTTCCAG-30) as a forward primer and
mAebp2-b (50-ATTGCAAATGTCGTTCACTGTTTGC
T-30) as a reverse primer for the fusion construct II, and
mAebp2-a (50-ATGGACATAGACAGCACAATTTCCA
G-30) as a forward primer and xbAebp2 (50-CTGAAGTG
TGTGGGTACATGGC-30) as a reverse primer for the
fusion construct III. These products were first subcloned
into the pCR4 TOPO vector (Invitrogen) for sequencing
verification, and later subcloned into the BamHI and
HindIII restriction enzyme sites of the pGEX-4T-1
vector (Amersham Biosciences). The clones were trans-
formed into the BL21 (DE3) competent cells (Strategen).
The transformed cells were grown in LB media in 37C to
an absorbance value of 0.56 at 600 nm. The cells were
further induced with 0.4 mM IPTG for 4 hours. The cell
pellets were first sonicated, and stored in –80C for later
use in gel shift assays.
Electro mobility shift assay (EMSA)
EMSAs were performed as suggested by Promega with
alterations in the DNA-binding buffer condition. For
most of our EMSAs, we mainly used the NTEN buffer
(100mM NaCl, 1mM EDTA, 20mM Tris–Cl pH 6.0,
0.5% NP40). Each reaction contained 10 mg of GST
fusion protein along with a given duplex probe (0.007
pmol per reaction), which were labeled with [g-32 P]
ATP. The information regarding the sequences of all the
duplex probes used for the current study is available upon
request.
ChIP cloning and individual ChIP assays with
anti-AEBP2 and anti-SUZ12 antibodies
We performed ChIP cloning experiments using two poly-
clonal antibodies: AEBP2 (Cat. 11232-2-AP, Proteintech
Group) and SUZ12 (Cat. ab12201, Abcam). The brain
tissues of a 1-month-old mouse were used as a starting
material, and the detailed protocol for our ChIP cloning
is available from our previous study (15). DNA products
eluted by anti-AEBP2 and SUZ12 ChIP were individually
subcloned into the pZErO-2 vector (Invitrogen, Carlsbad,
CA). About 200–300 clones were selected and subse-
quently sequenced using the ABI3130XL automated
DNA sequencer (Applied Biosystem).
For individual ChIP experiment, the AEBP2 antibody
(20ml) was added into each fraction (500 ml) of cross-
linked and sonicated mouse brain tissue. One mouse
brain (1 g) was usually divided into 10 fractions. We fol-
lowed the protocol of ChIP assay provided by the Upstate
company (Upstate Biotech.). The immunoprecipitated
DNA was dissolved in 40 ml of TE, and 1 ml of this
eluted DNA was used as template DNA for one PCR-
based ChIP assay. PCR conditions are as follows: 95C
for 5min, 40 repetitions of the following cycle of 90C
for 30 s, 60C for 30 s, 72C for 30 s, and final extension
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at 70C for 15min. Each reaction included a pair of 25 ng
of oligonucleotide primers. The information regarding the
sequence of each primer set is available as Supplementary
Data 4.
Motif analysis of ChIP-cloned sequences
Both 50- and 30-end regions, 4 bp in length, corresponding
to the recognition sites for restriction enzymes were
removed from each ChIP sequence for motif analyses.
Any regions containing repeat elements were also removed
from each ChIP sequence using RepeatMasker (http://
www.repeatmasker.org/cgi-bin/WEBRepeatMasker). Our
motif analyses used a total of 126 and 71 sequences that
were obtained from AEBP2 and SUZ12 ChIP-cloned
sequences, respectively. A standalone MEME (4.0.0)
(http://meme.sdsc.edu/meme/cgi-bin/meme.cgi) was used
to derive overrepresented motifs among each set of the
ChIP-cloned sequences. We set parameters to ensure
that at least a half of the sequences contain potential
motifs in each set of ChIP sequences using a ‘-minsites’
parameter. We used the following parameters: -minsites
(a half number of the sequences), -minw 5, -nmotifs 3,
-revcomp, -dna. MAST (4.0.0) (http://meme.sdsc.edu/
meme/cgi-bin/mast.cgi) was also used for the motif occur-
rence test with default setting.
RESULTS
Identification of AEBP2-related sequences from
vertebrates and flying insects
The protein sequence of mouse AEBP2 (GenBank acces-
sion no. NP_001005605, 496 amino acids long) was used
to identify its related sequences from all available genome
sequences. This search identified six AEBP2-related
sequences from flying insects, including flies, mosquitoes,
honeybees, beetles, and wasp. These insect sequences were
previously identified as JING. The same search also iden-
tified 22 related sequences from vertebrates, ranging from
urochordates to placental mammals: one sea urchin, five
fish, one lizard, one chicken, 14 mammal sequences.
The average sizes of the predicted ORFs (Open Reading
Frames) for these AEBP2-related sequences are as follow:
1744 amino acids for insects’ JING, 450 amino acids for
fish’s AEBP2, and 500 amino acids for mammalian
AEBP2. The sizes of the AEBP2 sequences identified
from lizard, frogs, sea urchins, cannot be determined
due to the incompleteness of their genome sequences.
All these AEBP2-related sequences are available as a
Supplementary Data 1.
The amino-acid sequences of 20 full-length
AEBP2-related sequences were used for global sequence
alignment (Figure 1). As shown in Figure 1, the mamma-
lian AEBP2 sequences can be divided into six protein
domains: acidic, neutral, serine-rich, zinc finger, basic
and lysine-rich domains. Among these six domains, two
domains (zinc finger and basic) show the highest levels of
amino-acid sequence conservation among all different
lineages. The two domains of the mammalian AEBP2
(a.a. 256–496 in mouse AEBP2 Figure 2A) show an aver-
age of 38% amino acid sequence identity with those of the
insect JING (Figure 2A). The serine-rich domain (a.a.
202–255) also shows high levels of sequence conservation:
83% amino acid sequence identity between the mammal
and fish lineage. In contrast, the two domains located in
the N-terminal portion of AEBP2 are lineage-specific.
Although these two domains show an average 90%
amino acid sequence identity between the mammalian
species, these domains do not show any obvious similarity
to the respective regions of the AEBP2 sequences derived
from insects and fish. The acidic domain of mammalian
AEBP2 is mainly characterized by arrays of glutamic and
aspartic acid residues, whereas the neutral domain is char-
acterized by arrays of glycines and serines. The AEBP2
sequences of the fish lineage also have similar acidic and
neutral domains, displaying 38% amino acid sequence
identity within the fish lineage. These two domains are
localized within one large exon in both mammals and
fish (Figure 2B), and the sequences of this exon in both
lineages exhibit tandem repeat structure with high CpG
densities. As such, many insertions/deletions are detected
between the two closely related species of both mammals
and fish (data not shown). On the other hand, the lysine-
rich domain located in the C-terminus of mouse AEBP2 is
found only in mammals, but is well conserved within
mammalian species (a.a. 497–511). Overall, mammalian
AEBP2 is comprised of six protein domains: four domains
are lineage-specific whereas two domains (zinc finger and
basic) appear to be well conserved throughout all the
lineages.
Exon structure and isoforms of mammalian AEBP2
Inspection of all the available cDNA and EST (Expressed
Sequence Tag) sequences derived from the mouse Aebp2
gene revealed that mouse Aebp2 is comprised of 11 indi-
vidual exons that spread over a 60-kb genomic interval in
Figure 1. Global protein sequence alignment of AEBP2 and JING.
AEBP2 and JING protein sequences of different organisms were
aligned using the ClustalW program. Different amino acids are repre-
sented in different colors and shades. The conservation level of each
position is indicated in the graph below the alignment. Six conserved
domains are indicated with different colors and patterns. The mouse
AEBP2 protein was used as a reference to indicate the position of each
conserved domain. The zinc finger and basic domains are the most
conserved and show sequence conservation from flying insects to mam-
mals. The zoom-in version of this alignment is available as
Supplementary Data 5 or the following website (http://jookimlab.
lsu.edu/?q=node/81).
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mouse chromosome 6 (Figure 2B). A single exon (exon 1b)
encodes both the acidic and neutral domains of mouse
AEBP2 (a.a. 1–201). The following three exons (exons
2–4) encode the serine-rich domain and the three zinc
finger units (a.a. 201–345), and the next four exons
(exons 5–8) encode the basic domain (a.a. 346–496).
This exon structure also involves two sets of alternative
splicing: one is between the two 50-end exons (1a and 1b)
and the other is between three individual 30-end exons
(8, 9a and 9b). The first alternative splicing yields the
two different forms of AEBP2 cDNAs: Isoform 1 with
exon 1b and Isoform 2 with exon 1a (Figure 2B).
The Isoform 1 cDNA has three potential START
codons that are in-frame with the rest of the AEBP2
exons. The first two are located within exon 1b, and the
third one is within exon 2. In contrast, exon 1a does not
contain any in-frame ATG codon, and thus the Isoform 2
cDNA starting from exon 1a likely uses the third START
codon located within exon 2. Since the two potential
START codons for Isoform 1 and 2 are separated by
222 amino-acid residues, a large protein size difference is
predicted between these two forms. Also, the acidic and
neutral domains should be included only in the larger
form (Isoform 1), but not in the smaller form (Isoform 2).
The second alternative splicing occurs between several
30-end exons: Exon 8, 9a and 9b. The first form of the
30-end alternative splicing simply ends at Exon 8 with its
STOP codon and 30-UTR (Figure 2B). The second form
splices out the 30-UTR of Exon 8, and join only the coding
region of Exon 8 (named Exon 8s) to another downstream
exon (exon 9a). Exon 9a has an additional 14-amino-acid-
long coding region with its STOP codon. In fact, this small
peptide region from exon 9a corresponds to the lysine-rich
domain that is conserved within every mammalian species
Figure 2. Exon structure and alternative splicing of the mouse Aebp2 gene. (A) The same colors and patterns as Figure 1 were used to represent
different protein domains. The percent identities were calculated through comparing the amino-acid sequences of AEBP2 from individual organisms
vs. the mouse. The N terminus of the insects’ JING (dotted-lines) was omitted in this comparison due to the lack of any detectible sequence
similarity. The AEBP2 of the fish lineage also has similar acidic and neutral domains, but these do not show any similarity to those of mammalian
AEBP2 (indicated with a green box). (B) Isoforms and stage-specific expression of the mouse Aebp2. A total of 11 exons have been found in the
mouse Aebp2 so far. Three START codons are indicated: two within Exon 1b and the third one in Exon 2. Three STOP codons are also indicated
within exons 8, 9a and 9b. Alternative splicing of these exons could result in at least six different isofoms, including the two major forms detected in
this study, Isoform 1 (52 kDa) and Isoform 2 (31 kDa). (C) Alternative splicing confirmed through RT–PCR. This analysis used total RNA from
individual tissues, the different amounts of which were normalized to an internal control gene, p53. The combination of exons 1a and 2 is highly
expressed in a 14-day-old embryo, which belongs to Isoform 2. (D) Western blot of the mouse AEBP2. Isoform 1 (52 kDa) is dominant in the most
tissues examined, while Isoform 2 (31 kDa) was detected only in a 14-day-embryo.
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(Figures 1 and 2A). The third form of the 30-end alterna-
tive splicing connects exon 8s to another further down-
stream exon (exon 9b), and this form also has an
additional 7-amino-acid-long coding region. The evolu-
tionary conservation of this exon is, however, currently
unknown. According to our own survey on ESTs and
cDNAs, most cDNAs derived from different tissues start
with exon 1b and end with exon 8 (496 a.a. long), but a
subset of cDNAs from early embryonic stages start with
exon 1a, and end with either exons 8 or 9a (274 or 288 a.a.
long). The other combinations of cDNAs are also likely,
but the above two forms are believed to be the major
forms for mouse AEBP2 cDNAs.
The two sets of alternative splicing predicted from
cDNA sequences were tested through RT–PCR-based
experiments using total RNAs isolated from several
mouse tissues and cell lines (Figure 2C). As shown in
Figure 2C (second and third row), the exon combination
of 1b and 2 (1b+2) was detected throughout all the tis-
sues tested. The exon combination of 1a and 2 (1a+2)
was similarly detected in all the samples except the
Neuro2A cell line. The overall expression levels of the
1b+2 combination were higher than those of the
1a+2 combination. However, this trend was reversed in
the embryonic tissues: the expression of the 1a+2 com-
bination was much higher than that of the 1b+2 combi-
nation. This is also consistent with the fact that all of the
available EST clones containing the 1a+2 combination
were derived from early embryonic tissues. The detection
of these two alternative first exons further suggests the
presence of two alternative promoters for mouse Aebp2:
one may be responsible for the ubiquitous expression
whereas the other one for the embryo-specific expression.
We also performed another set of RT–PCR analyses to
confirm the presence of the 30-end alternative splicing
(Figure 2C, fourth and fifth row). Since exon 9a is still
part of the 30-UTR of exon 8, we avoided testing the
second exon combination (7+8s+9a). We mainly ana-
lyzed two different combinations of the 30-end alternative
splicing (7+8 and 7+8s+9b). Both exon combinations
were detected in most of the tissues examined, but the
expression levels of the 7+8 combination appear to be
higher than those of the 7+8s+9b combination.
Overall, RT–PCR analyses indeed confirmed the presence
of two alternative splicing, and detected somewhat stage
and tissue specificity of these splicing.
We further tested the presence of multiple isoforms of
the AEBP2 protein with western blot experiments using a
polyclonal antibody raised against the human AEBP2
protein (Figure 2D). This analysis detected two main
forms of AEBP2 (52 and 31 kDa, respectively). The
larger form (52 kDa) was detected in the HeLa nuclear
extracts as well as in the several tissues of the mouse,
including brain and testis. Detection of another band in
the brain sample was likely caused by non-specific binding
to other unknown proteins. The 52-kDa protein appears
to correspond to the largest ORF predicted from Isoform
1 cDNAs based on its similar size and ubiquitous expres-
sion in most tissues. In the brain of a 14-day-old embryo,
however, the same analysis detected only the smaller form
(31 kDa). The 31-kDa protein likely corresponds to the
ORF derived from Isoform 2 cDNAs based on its smaller
size and limited expression in embryonic stages. Due to
the limited separation capability of SDS-PAGE gel elec-
trophoresis, however, it is currently unknown whether
these two isoforms also have different C-terminal endings,
as predicted from the 30-end alternative splicing.
Nevertheless, the above analysis confirmed the existence
of two major forms of AEBP2 in vivo: the adult-specific
larger form (52 kDa) and the embryo-specific smaller form
(31 kDa).
DNA-binding motifs of AEBP2
To characterize DNA-binding motifs for AEBP2, we
made three GST-fusion constructs containing different
isoforms of mouse AEBP2: Construct I (a.a. 1–496) cor-
responding to the 52-kDa larger form, Construct II (a.a.
223–496), corresponding to the 31-kDa smaller form, and
Construct III (a.a. 223–348), corresponding to a truncated
version lacking the basic domain. All of these GST-fusion
proteins were successfully expressed in bacteria. However,
only the two GST-fusion proteins from Constructs II and
III exhibited some levels of DNA-binding activity. The
reason for the inactivity of the GST-fusion protein I is
currently unknown. We also tested the binding capability
of the GST-fusion protein II to the sequences of several
individual DNA fragments, which have been derived from
ChIP cloning experiments designed to identify the in vivo
target loci of the AEBP2. This will be described in detail in
the following section. Among these short sequences, one
sequence named T1 showed consistently high levels of
DNA-binding affinity to the GST-fusion protein II.
Thus, we have selected and used this particular sequence
as a main probe for our DNA-binding motif assays
(Figure 3).
Several mutant series of the T1 duplex probes were
designed and used for our DNA binding motif studies of
AEBP2. First, an internal 28-bp-long region of the T1
sequence (8th to 35th position) was divided into four indi-
vidual 7-bp-long sections, and the sequence of each section
was changed into a 7-bp-long stretch of A’s (Probe II-1
through 4). Each of these mutant probes was used as a
competitor to the P32-labeled T1 probe for gel shift assays
(Figure 3A). A shift band was completely abolished in a
self-competition experiment, using a 100 to 1 molar ratio
of the P32-unlabeled to labeled probes (Figure 3A, Lane
1). Similarly, the third mutant (lanes 6 and 7) competed
and abolished the band, indicating that this region is dis-
pensable for the binding activity. In contrast, the three
remaining mutants did not compete at all (lanes 2, 3, 4,
5, 8, 9), indicating that the three regions covered by these
mutants are important for the binding to AEBP2. This
initial series of competition experiments demonstrated
that the two regions (8th to 21st and 29th to 35th position)
of the T1 sequence are critical for the binding to AEBP2.
These two regions were further analyzed using a second
series of mutants, each of which has a 3-bp-long stretch of
A’s (Figure 3B). This series of experiments identified 3
smaller regions showing relatively weak competition
(Figure 3B, lanes 6, 8, 9, marked with asterisk), indicating
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that these three small regions (CTT, CAG, GCC) are
likely critical for the binding to AEBP2.
We also performed another independent series of gel
shift assays using the DNA sequences derived from the
20 shortest DNA fragments derived from the ChIP
cloning experiments using the AEBP2 and SUZ12 antibo-
dies (Figure 4). This survey identified four individual
sequences showing high levels of binding affinity to
AEBP2 (Figure 3C, S8, S10, AB-13 and S17). Further
inspection of the four sequences, averaging 50 bp in
length, revealed that all of these sequences share two
small motifs with the T1 sequences, CTT and GCC.
However, the distance between these two motifs is some-
what variable among these potential binding sites of
AEBP2, ranging from 15 to 23 bp in length. Thus, the
effect of spacing between motifs was tested using two
mutants of the T1 sequences (Figure 3D, lanes 6–9). The
spacing region of the T1 sequence was either deleted
(Zipped) or duplicated (Wide). The Zipped probe did
not compete but the Wide probe competed very well,
demonstrating that the spacing between the two motifs
requires some minimum distances, but that the size can
be variable without any major effect on the binding affin-
ity to AEBP2. We also tested the binding affinity of the
Figure 3. DNA-binding motifs of AEBP2. Gel shift assays of the GST-AEBP II fusion proteins. (A) Competition assay with the first series of
mutants (II-1, II-2, II-3, II-4). Each contains an internal 7-bp-long region substituted with a stretch of As. (B) Competition assay with the second
series of mutants. Each contains a 3-bp-region substituted with a stretch of As. Mutants 6, 8 and 9 did not compete well (as indicated with asterisk),
and thus these three small regions are thought to be the most critical for the AEBP2 binding. (C) The T1 probe was also competed with other short
sequences derived from the ChIP cloning experiment using the AEBP2 antibody. The actual sequences for these ChIP fragments are shown on the
right column. (D) Competition assay with different probes: the AE-1 probe from the original sequence that was used to identify the AEBP2 (1), the
AB-13 probe from an independent ChIP-derived sequence with high affinity to AEBP2, the Zipped probe with the II-3 region removed and the Wide
probe with the II-3 region duplicated.






/nar/article/37/9/2940/1153200 by Louisiana State U
niversity user on 04 O
ctober 2021
original sequence that was used to identify the AEBP2
protein ((1); AE-1, lanes 2 and 3). This sequence competed
at some levels, but the binding affinity was much lower
than the other sequences used for this study. We repeated
the above experiments using GST-fusion protein III,
which lacks the basic domain. The results did not show
any difference from those of GST-fusion protein II (data
not shown). This suggests that the three Gli-type zinc
finger motifs shared by both fusion proteins are mainly
responsible for the DNA-binding activity of AEBP2. In
sum, the above series of experiments identified a DNA-
binding motif for AEBP2, which displays an unusual
bipartite motif structure, CTT(N)15-23cagGCC with the
lowercase bases being less critical for binding.
ChIP cloning of in vivo target loci bound by AEBP2
and SUZ12 proteins
A series of ChIP cloning experiments were performed to
identify in vivo target loci bound by AEBP2 (Figure 4). We
previously developed a modified version of ChIP cloning
method, which can be used to directly clone very short
DNA fragments without PCR amplification (15). This
method performs restriction enzyme digestion with 4-bp
cutters, such as Sau3AI or Tsp509, directly on the DNA
while it is still cross-linked to a target protein as a chro-
matin complex. This enzyme digestion usually generates
much shorter DNA fragments that are compatible with
subcloning. Using two polyclonal antibodies against
AEBP2 and SUZ12, we have generated two individual
libraries containing ChIP-derived DNA fragments. We
have sequenced a subset of these two libraries, 250 and
165 clones for AEBP2 and SUZ12, respectively. The aver-
age length of the inserts from each library was about 140
bp in length. Individual sequences are available as
Supplementary Data 2 and also the associated informa-
tion can be viewed using a custom track view of the UCSC
genome web browser (http://genome.ucsc.edu/cgi-bin/
hgTracks?db=mm9&hgt.customText=http://jookimlab.
lsu.edu/sites/default/files/Aebp2_bed.txt).
Initial inspection of the sequences from these two
libraries derived the following conclusions. First, both
libraries contain fractions of repeat sequences, 124/250
for the AEBP2 set and 94/165 for the SUZ12 set.
Second, the remaining non-repeat sequences of both sets
mapped closely to gene regions of the mouse genome. The
list of the genes associated with each set was compared
with the list of the mouse genes that are known to be
bound by the PRC2 (16). This comparison confirmed
that 53 out of the 126 sequences of the AEBP2 set
(42%) were derived from the known PcG target loci
while 18 of the 71 sequences of the SUZ12 set (25%)
came from the PcG target loci. It has been shown that
only a small fraction of mammalian genes are controlled
by the PRC2 (less than 5% of the entire gene set of mam-
mals) (16). Thus, the observed high levels of enrichments
of the PcG downstream genes among the ChIP cloning
sets of AEBP2 (42%) and SUZ12 (25%) strongly suggest
that both proteins, AEBP2 and SUZ12, are likely involved
in the targeting of the PRC2 complex. Some of the notable
Figure 4. ChIP cloning scheme and experimental strategies. Our modified ChIP cloning method has one additional step compared to other existing
protocols: the restriction enzyme digestion step (step 4) right before the elution step. This allows immediate cloning of shorter ChIP DNA fragments
without PCR amplification. Also, this shortening of ChIP fragments further trims other unnecessary long regions from either side of each ChIP
fragment while preserving the actual binding site for a given DNA-binding protein. This further facilitates accurate prediction of DNA-binding
motifs. The isolated ChIP fragments were subsequently used for the following three experiments. First, we used the sequences derived from the
shortest ChIP fragments as probes for our gel shift assays of AEBP2. Second, we used the sequences from the ChIP cloning to identify enriched
DNA motifs. Third, we also identified in vivo target loci for both AEBP2 and SUZ12. These confirmed loci were later tested for the co-occupancy by
AEBP2 and SUZ12.
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PcG loci that were identified through our ChIP cloning
trials include: Grm8, Abcc3, and Phkb from the AEBP2 set
and Pax1, Acvrinp1 and A20Rik from the SUZ12 set.
The summary of this comparison is available as
Supplementary Data 3.
Third, analysis of the non-repeat sequences by the
MEME program (http://meme.sdsc.edu/meme/intro.html)
revealed the presence of several DNA motifs that were
overrepresented within each set of ChIP sequences. The
two most significant motifs from each set are shown in
sequence logo format (Figure 5). The first motif of the
AEBP2 set is 22 bp long, and shared by 77 out of the
126 individual sequences. Interestingly, this motif contains
several small regions showing sequence similarity to the
two 3-bp-long critical regions, which were shown to be
critical for the binding to AEBP2 by our previous gel
shift assays, CTT and GCC (Figure 3). We performed
another gel shift assays using several AEBP2-ChIP frag-
ments, which are shown in Figure 5B, and the results con-
firmed again that these ChIP fragments indeed contain the
DNA-binding sites for AEBP2 (Supplementary Data 6).
The second motif from the AEBP2 set is also 22 bp long,
and displays a somewhat similar C-rich consensus
sequence as the first motif. This motif is shared by the
56 individual sequences of the AEBP2 set. Similar analyses
also identified two motifs from the SUZ12 set, which are
shared by 45 and 35 sequences of the total 71 individual
sequences, respectively. It is interesting to note that both
motifs contain small regions similar to the GAGA motif,
which is a frequent DNA motif in the Polycomb Response
Element (PRE) of Drosophila (10,17). However, the two
motifs from the SUZ12 set are shorter and also shared by
fewer of the individual sequences than the two motifs from
the AEBP2 set. This suggests that the sequences of the
SUZ12 set are more heterogeneous than those of the
AEBP2 set. In sum, many in vivo target loci of AEBP2
appear to be derived from the known PcG target regions,
and these loci display C-rich sequences with several small
motifs, which are reminiscent of the two critical DNA-
binding sites of AEBP2.
Co-occupancy test with AEBP2 and SUZ12 ChIP assays
The identified genomic loci by AEBP2 and SUZ12-ChIP
cloning were further analyzed using individual ChIP
experiments (Figure 6). These individual ChIP experi-
ments were performed to measure what fraction of each
library contains genuine in vivo target loci for each pro-
tein. According to the results from four different trials, 18
out of 19 tested loci from the AEBP2 set showed consis-
tent enrichment with the AEBP2 antibody, indicating that
about 94% of the AEBP2 set likely contains genuine
in vivo target loci. A similar test indicated that about
70% of the SUZ12 set (16/23) likely contains in vivo
target loci. The representative results from these series
of ChIP experiments are shown in Figure 6A and the
remaining portion of the results along with other relevant
information are also available as Supplementary Data 4.
Since AEBP2 is a potential targeting protein for PRC2,
we further tested this possibility through performing co-
occupancy tests. If the two proteins, AEBP2 and SUZ12,
bind to target loci together as a protein complex, many
confirmed target loci from one protein (AEBP2) should be
also positive with another ChIP experiment using the anti-
body against the second protein (SUZ12), and vice versa.
The results from this co-occupancy test are as follows.
Out of the 19 AEBP2 loci tested, 15 (79%) were positive
with the SUZ12-ChIP experiments. None of the nega-
tive loci from the AEBP2-ChIP were positive with
Figure 5. Enriched motifs within the AEBP2 and SUZ12 ChIP sequences. Motifs were predicted with each set of AEBP2 and SUZ12-ChIP
sequences using the MEME program (http://meme.sdsc.edu/meme4/cgi-bin/meme.cgi). (A) The two most significant motifs identified from each
set are shown in the sequence logo format. (B) The most significant motif from the AEBP2 set was shown with the two small motifs, which
have been also independently identified through gel shift assays. This most significant motif was also aligned with 20 individual sequences.
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the SUZ12-ChIP. On the other hand, 16 out of the 23
confirmed loci of the SUZ12 set (70%) were also positive
with the AEBP2-ChIP. We also extended this co-occu-
pancy test to the known target loci of the PcG complex.
Out of the six loci tested, three loci turned out to be pos-
itive with both AEBP2 and SUZ12-ChIP experiments
(Figure 6A and B; Supplementary Data 4). We also
included YY1 ChIP experiments to test if these loci are
bound by YY1. None of the tested loci were positive with
the YY1-ChIP, suggesting that YY1 may not be involved
in the targeting of the mammalian PRC2 to these loci. The
HoxA9 locus was analyzed in further detail by including
two additional primer sets. The precise PcG target region
within this locus is located 3.75-kb upstream of the gene as
demonstrated in the high levels of the DNA enrichment by
the SUZ12-ChIP experiments (Figure 6B). The two other
regions also show some levels of the enrichment with the
SUZ12-ChIP, which is consistent with the previous study
(7). However, the AEBP2-ChIP showed high levels of the
enrichment only at the 3.75-kb upstream region,
demonstrating high levels of target selectivity by the
AEBP2-ChIP experiment. In sum, the co-occupancy
tests revealed that an unusually large fraction of in vivo
target loci are co-occupied by both AEBP2 and SUZ12
proteins, further supporting the initial idea that AEBP2 is
likely a targeting protein for PRC2.
DISCUSSION
In the current study, we have characterized AEBP2 in
terms of evolutionary conservation, genomic structure,
DNA binding motifs and potential targeting roles for
the Polycomb group repression complex 2 (PRC2).
AEBP2 contains two evolutionarily conserved protein
domains, the zinc finger and basic domains, and these
two domains are also shared by the flying insect protein
JING. jing has recently been recognized as a member of
the PcG in Drosophila. Mammalian AEBP2 is driven by
two alternative promoters and produces at least two major
forms of the protein, and these isoforms show develop-
mental stage-specific expression patterns: the adult-
specific larger form (52 kDa) and the embryo-specific
smaller form (31 kDa). The AEBP2 protein binds to a
DNA-binding motif with an unusual bipartite structure,
CTT(N)15-23cagGCC. A large fraction of AEBP2’s
target loci also map closely to the known target loci of
the mammalian PRC2. We further confirmed that many
of these loci are indeed co-occupied by the two proteins
AEBP2 and SUZ12. This supports the prediction that
AEBP2 is a targeting protein for the mammalian PRC2
complex.
Global alignment of 20 AEBP2 sequences identified two
evolutionarily conserved domains, the zinc finger and
basic domains, which are located at the C-terminus of
the protein (Figure 1). These two domains maintain very
high levels of sequence conservation throughout all the
vertebrates, greater than 80% sequence identity in the
280 amino-acid long region. Similar domains are also
found even in the flying insect protein JING, sharing an
overall 38% sequence identity with AEBP2 (Figure 2A).
Although the observed sequence similarity is relatively
low, the insects’ jing is thought to be a homolog to verte-
brates’ AEBP2 based on the following reasons. First,
although the zinc finger domains of both genes are com-
prised of three typical Gli-type finger units that are quite
prevalent in eukaryotic genome, the 2nd finger shows rel-
atively high levels of sequence similarity (63%) between
the two groups. Interestingly, the second finger is also
three amino acids longer than typical Gli-type finger
units (1). Yet, this unique variation is also detected in all
the sequences of both AEBP2 and JING proteins
(Supplementary Data 1). Second, the basic domain is
characterized by a stretch of basic (Lys and Arg) amino-
acid residues at the beginning and another stretch of
hydrophobic (Leu, Val and Ile) and aromatic (Phe, Tyr
and Trp) amino acid residues at the end. According to
database search, this unusual domain is only found in
the two proteins, AEBP2 and JING. Furthermore, the
unique combination of this novel basic domain along
with three Gli-type zinc finger units is found again only
Figure 6. Co-occupancy test of the gene loci identified through AEBP2
and SUZ12 ChIPs. (A) Co-occupancy test of the genes identified from
AEBP2 and SUZ12-ChIP sequencing. The left panel indicates the genes
derived from each round of ChIP sequencing. Grm8, Abcc3 and Phkb
were derived from the AEBP2-ChIP sequencing, while Pax1, Acvrinp1
and A20Rik were from the SUZ12-ChIP sequencing. The three loci
(Grm8, Abcc3 and Phkb) were first tested through individual ChIP
assays using the AEBP2 antibody, and later using another antibody
(SUZ12) for the co-occupancy test. This was also repeated for the
SUZ12 set (Middle). A subset of the known Polycomb target loci
(Barx1 and Zic1) were also included for the co-occupancy test
(bottom). (B) Co-occupancy of AEBP2 and SUZ12 on the HoxA9
locus. The co-occupancy of AEBP2 and SUZ12 was only detected at
the 3.75-kb upstream region of the transcription start site of HoxA9.
We also performed another independent ChIP using the YY1 antibody
to test if YY1 is also involved in the targeting of the PRC2 to these
loci.
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within these two proteins. Therefore, it is highly likely that
vertebrates’ AEBP2 and the flying insects’ JING have
been derived from a common ancestor. According to
recent genetic studies in flies, the jing locus genetically
interacts with several members of PcG members (4).
This further suggests that AEBP2 and JING still play a
similar role, perhaps in the PcG-mediated repression. If
this is the case, the two conserved domains likely play the
most central roles for this repression mechanism, DNA
binding by the zinc finger units and protein–protein inter-
action by the basic domain.
One of the unexpected features associated with the
Aebp2 gene is the presence of several combinations of
alternative splicing, which involve the 50-end two exons
and 30-end three exons (Figure 2B–D). In principle, six
different types of AEBP2 protein isoforms are possible
although we have detected only two major forms through
western blot analyses. The expression of these two major
forms is very developmental stage-specific: the larger form
(52 kDa) is mainly detected in adult tissues, whereas the
smaller form (31 kDa) is found only in embryonic tissues.
This stage-specific expression is thought to be driven by
the two different promoters located upstream of the two
alternative first exons. According to our own surveys
using the EST database, a similar 50-end alternative spli-
cing of AEBP2 is also detected in other mammals, and the
expression of each of the two splicing variants can be
easily categorized into either embryonic or adult-specific.
In the other vertebrates and invertebrates, however, there
appears to be only one first exon for AEBP2 and JING,
and also the expression pattern of this cDNA form
appears to be spatially and temporally ubiquitous. This
suggests that the alternative splicing of AEBP2 and
stage-specific expression are unique features found only
in mammals. Then, what is the major impetus for the
sudden implementation of this alternative splicing for
the mammalian AEBP2? This could be explained by the
actual products of the alternative splicing: a smaller
embryonic form with two conserved domains versus a
larger adult form with additional lineage-specific domains
(Figure 2). Given the similarities in domain structure
between the smaller form and other vertebrate AEBP2
proteins, the smaller form is likely involved in more fun-
damental biological processes than the larger form, such
as determining the pattern and axis of animal body during
early development. On the other hand, the larger form
with lineage-specific protein domains is likely involved in
cellular processes that are more species-specific, such as
determining the lineage and location of different cell
types within the adult tissues. It is interesting to note
that the smaller form with conserved domains participates
in earlier developmental processes than the larger form
with additional lineage-specific domains. This could be
another case of ontogeny recapitulating phylogeny in
animal evolution (18). Overall, the alternative splicing
and subsequent formation of mammalian AEBP2
isoforms represents a case where alternative splicing has
driven functional division and adaptation of genes.
According to DNA-binding motif studies (Figure 3),
AEBP2 binds to a consensus sequence with bipartite struc-
ture, CTT(N)15-23cagGCC, and this binding is mainly
driven by the three zinc finger units. This consensus
DNA-binding motif has been further substantiated by
the independent observation that the in vivo target loci
of AEBP2 also show similar motifs (Figure 5). However,
the AEBP2 binding to a bipartite structure motif was
unexpected given the fact that the three zinc finger units
are juxtaposed right next to each other. This suggests that
the recognition of the two smaller motifs within the bipar-
tite motif, which is separated by a spacing, (N)15-23, may
be driven by individual zinc finger units of either one or
two proteins. The model of single protein binding posits
bending of the DNA because of the predicted close prox-
imity between individual fingers, whereas the model invol-
ving binding by two proteins hypothesizes potential dimer
formation of the AEBP2 protein. We favor the first model
based on the following reasons. First, the truncated ver-
sion of AEBP2, GST-fusion protein III, lacks any
domains that could function in dimerization, still
showed unchanged binding preference to the bipartite
motif (data not shown). Second, the bipartite motif
tends to show higher affinity to AEBP2 when the spacing
region, (N)15-23, of the bipartite motif is either homopo-
lymeric or polypyrimidine stretch sequences, such as
polyA or poly(CT). These types of sequences are known
to be common in bending regions of the genome (19). This
is further supported by our independent observation that
many confirmed target loci of AEBP2 also exhibit poly-
pyrimidine sequence structures (Figure 5). Although we
cannot rule out the other possibilities of DNA binding
driven by the dimer structure of AEBP2, the above results
suggest potential binding of AEBP2 to bent DNA.
The co-occupancy test with the ChIP experiment clearly
demonstrated that AEBP2 and SUZ12 bind to similar
genomic regions (Figure 6). Since none of the PRC2
core proteins are known to be DNA-binding proteins,
this further implicates that AEBP2 may act as a targeting
protein for this complex. According to our recent data
from a mouse model disrupting the Aebp2 locus (H.
Kim et al., unpublished results), some of the known PcG
downstream genes are indeed de-repressed in these mutant
mice (Supplementary Data 7), further confirming this pos-
sibility. Also, the previously reported activity of AEBP2 as
a transcriptional repressor supports this possibility (1).
However, we do not predict all of the identified target
loci of AEBP2 to be PcG target loci based on the follow-
ing reasons. First, we expect that AEBP2 should be also
involved in many other cellular processes besides the pre-
dicted PcG-targeting role based on its evolutionary age
and also various protein isoforms detected in mammals.
YY1 is an example of a similar case: its role has diversified
tremendously from its original evolutionarily conserved
role in the Polycomb-mediated repression since the split
of insects and vertebrates (20,21). Second, as demon-
strated in flies, PcG targeting is likely mediated through
a combination of several DNA-binding proteins along
with critical DNA structures which are yet unrevealed
(17). A similar conclusion has been drawn from the cur-
rent study: although many SUZ12 confirmed loci are also
bound by AEBP2, the DNA-binding motifs of AEBP2
were not significantly overrepresented in this pool of the
genomic sequences (Figure 5). This suggests that AEBP2






/nar/article/37/9/2940/1153200 by Louisiana State U
niversity user on 04 O
ctober 2021
may be one of several DNA-binding proteins involved in
the targeting of the mammalian PRC2. In that regard,
characterizing the functional contexts of each of the
AEBP2 binding to the identified in vivo target loci will
be of great interest in the near future.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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